The group of investigators from the RIETE Registry showed 5 lectures and 2 oral communications

In early March, Barcelona hosted the 7th International Symposium to be on Women’s Health Issues in Thrombosis and Haemostasis (WHITH), a meeting to show and discuss new findings in women’s health related to venous thromboembolic disease (VTE) and mechanisms related to bleeding.

The group of investigators from the RIETE registry showed 5 lectures and 2 oral communications in which, thanks to data provided by the registry (more than 70.000 patients with VTE to date), the following aspects of women’s health related to VTE were studied:

  • Uterine bleeding is frequent in women under anticoagulant therapy, especially if they are young, and apart from VTE, they suffer from cancer, anemia or blood problems.
  • After discontinuation of anticoagulant therapy, chances of a new thrombotic episode are slightly higher in women who had a hormonal treatment when compared to those who had other transitory risk factors.
  • Evolution of men and women with VTE and lung, colon, pancreas, stomach or blood cancer is similar during anticoagulant therapy.
  • Women who undergo an assisted reproduction treatment have more probabilities of developing a pulmonary embolism than women who get naturally pregnant.

During the three days of the WHITH, other studies non-related to RIETE group were also displayed. The following are relevant to be highlighted:

  • Medical guidelines do not make any gender distinction, in the recommendations for VTE prophylaxis in patients with cancer. However, women actually need some specific recommendations.
  • In postmenopausal women with breast cancer who need a hormonal treatment, it is better to appeal to aromatase inhibitors than tamoxifen as a measure for decreasing VTE risk.
  • Low molecular weight heparin is not recommended for preventing placenta complications during pregnancy
  • VTE is one of the main mortality causes among pregnant women in the Western World.
  • Venous thrombosis is the most frequent VTE manifestation among under age population.



Last news